February 6, 2018
RegMed Investors’ (RMi) pre-open: the tumble down game
February 5, 2018
RegMed Investors’ (RMi) pre-open: roll over Beethoven
February 2, 2018
RegMed Investors’ (RMi) pre-open: the known unknowns as the market is headed for a big sell-off
February 1, 2018
RegMed Investors’ (RMi) pre-open: appreciation in tempestuous times
January 31, 2018
RegMed Investors’ (RMi) pre-open: not everything is a BUY after a dramatic dip
January 30, 2018
RegMed Investors’ (RMi) pre-open: wandering the downside
January 29, 2018
RegMed Investors’ (RMi) pre-open: viability, the ability to survive and reward shareholders
January 26, 2018
RegMed Investors’ (RMi) pre-open: sector companies need to reduce their risk profile to satisfy a conviction BUY
January 25, 2018
RegMed Investors’ (RMi) pre-open: volatility is unpredictable
January 24, 2018
RegMed Investors’ (RMi) pre-open: sentiment is an attitude which allows momentum to be measurable
January 23, 2018
RegMed Investors’ (RMi) pre-open: the “JUNO” effect
January 22, 2018
RegMed Investors’ (RMi) pre-open: riding the upside as Celgene (CELG) prices acquisition of Juno Therapeutics (JUNO) at $87 per share or $9 B
January 19, 2018
RegMed Investors’ (RMi) pre-open: time to skim the profit of some upsiders
January 18, 2018
RegMed Investors’ (RMi) pre-open: the question is, do you feel the sentiment?
January 17, 2018
RegMed Investors’ (RMi) pre-open: Celgene’s (CELG) expresses its interest in Juno Therapeutics (JUNO)
January 16, 2018
RegMed Investors’ (RMi) pre-open: the indexes and ETFs tease the sector, follow us
January 12, 2018
RegMed Investors’ (RMi) pre-open: momentum has been fading in and out
January 11, 2018
RegMed Investors’ (RMi) pre-open: show me ROI
January 10, 2018
RegMed Investors’ (RMi) pre-open: what matters?
January 9, 2018
RegMed Investors’ (RMi) pre-open: where’s the meat?
January 5, 2018
RegMed Investors’ (RMi) pre-open: dips pre-JP Morgan could foretell another equity slippery slope
January 4, 2018
RegMed Investors’ (RMi) pre-open: the sector re-upsides
January 3, 2018
RegMed Investors’ (RMi) pre-open: the upside, a game of cues
January 2, 2018
RegMed Investors’ (RMi) pre-open: many sector equities are starting 2018 at bottoms
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.